Rebalance, LLC Revelation Biosciences, Inc. Put Options Transaction History
Rebalance, LLC
- $1.36 Trillion
- Q3 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding REVB
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About REVELATION BIOSCIENCES, INC.
- Ticker REVB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,525,800
- Market Cap $10.6M
- Description
- Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...